Bioengineering is one of the fastest growing and most impactful technology domains in our world today. This symposium will feature keynote presentations by four of bioengineering’s leading innovators who will highlight their exciting research advancing the leading edge in precision medicine, biomaterials for drug delivery, cellular manufacturing and in our fundamental understanding of biological systems:
- Steve Quake, Lee Otterson Professor of Bioengineering, Co-President Chan-Zuckerberg Biohub and Professor of Applied Physics, Stanford University
- Tejal Desai, Ernest L. Prien Professor and Chair, Department of Bioengineering and Therapeutic Sciences, UCSF
- Jay Keasling, Professor of Chemical Engineering and Bioengineering, UC Berkeley and Senior Faculty Scientist and Chief Science and Technology Officer for Biosciences, Lawrence Berkeley National Laboratory and CEO, Joint BioEnergy Institute
- Karl Deisseroth, D.H.Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences, Stanford University and HHMI
Registration Deadline is Friday, March 15, 2019. Space is limited, so please register early.